Enter a keyword or phrase to search all pages in this section:


Advanced search

Archive:

Looking for a previously published document in this section?

Class 2 Drug Alert (Action within 48 hours): Ferring Pharmaceuticals Ltd - Zomacton 10 mg powder for reconstitution with diluent, Somatropin (rbe)

Document details:

Type: Drug Alert
Series No: EL (11)A/19
Audience: Healthcare professionals
Published: 4 July 2011
Format: Electronic only
Size: A4
Pages: 2
Price: Free
ISBN/ISSN: None
Author:
Copyright: Crown
   

Help viewing PDFs:

DRUG ALERT

CLASS 2 MEDICINES RECALL
Action within 48 hours
For distribution to GPs, pharmacies, wholesalers and relevant clinics
04 July 2011 EL (11)A/19 Our ref:  MDR 67-06/11

Dear Healthcare Professional,

Ferring Pharmaceuticals Ltd

Zomacton 10mg powder for reconstitution with diluent, Somatropin (rbe)

PL 03194/0104

Batch number Expiry date Pack size  First distributed 
CD0382G Jun-11 1 vial and 1 diluent syringe 13/01/2010
CD0552D  Aug-11  1 vial and 1 diluent syringe  12/05/2010 
CD0552G Nov-11  1 vial and 1 diluent syringe  30/03/2010
CD0640A Nov-11 1 vial and 1 diluent syringe  18/04/2010
CD0640E Nov-11 1 vial and 1 diluent syringe  15/06/2010
CD0640K Nov-11 1 vial and 1 diluent syringe  09/07/2010
CE0192B Feb-12 1 vial and 1 diluent syringe  30/07/2010
CE0327E Jun-12 1 vial and 1 diluent syringe  11/11/2010
CE0327G May-11 1 vial and 1 diluent syringe  18/10/2010
CE0481C Jun-12 1 vial and 1 diluent syringe  17/12/2010


Ferring Pharmaceuticals Ltd is recalling all remaining stock of the above batches to wholesaler, pharmacy and clinic level. The preservative levels in a small number of the prefilled diluent syringes are below specification but remain at levels not expected to pose a significant patient risk. The problem is estimated to affect less than 0.6% of the syringes.

For medical information enquiries please call Ferring Pharmaceuticals Ltd on 08449 310054.

All unused stock of these batches should be quarantined and should be held in refrigerated condition (2°C to 8°C). Please wait for instructions from the original supplier with regard to returning stock for credit. For enquiries relating to stock returns please call Ferring Pharmaceuticals Ltd on 08449 310052.

Recipients of this Drug Alert are requested to bring it to the attention of relevant professionals by copy of this letter. Primary care trusts are asked to forward this information to general practitioners, community pharmacists and relevant clinics.

Yours faithfully

Ian Holloway
MHRA DMRC Manager

MHRA Distribution (further recipients by cascade):


Regional contacts for NHS trusts and provider units
Chief Pharmacists: England, Scotland, Wales, Northern Ireland
Prison Health Policy Unit (DH)
Chief pharmacists: Jersey, Guernsey, Alderney, Sark, Isle of Man, Gibraltar
Special Hospitals
Healthcare Commission for distribution to Independent Health Care Establishments
Primary care trusts (England)

Page last modified: 05 July 2011